ACTC1 and chronic myelogenous leukemia, BCR-ABL1 positive: Analysis of key differentiation genes indicate cells are primed to undergo meso-endodermal differentiation with ACTC1, MESP1 and PODXL all being upregulated following dual inhibition of CML-iPSCs (Fig. 7d).